1. CORESTA Congress, Quebec, 2014, Smoke Science/Product Technology Groups, ST 81

    Clinical trial to compare smoking cessation rates with Camel SNUS and a nicotine lozenge – Part 1: Study Design

    NELSON P.R.; CHEN P.
    R.J. Reynolds Tobacco Company, Winston-Salem, NC, U.S.A.
    R.J. Reynolds conducted a multicenter clinical trial to compare smoking cessation rates when healthy smokers with the intent to quit were switched to Camel SNUS or a nicotine lozenge. The primary objectives of the study examined whether SNUS was...
  2. CORESTA Congress, Quebec, 2014, Smoke Science/Product Technology Groups, ST 82

    Clinical trial to compare smoking cessation rates with Camel SNUS and a nicotine lozenge – Part 2: Results

    NELSON P.R.; CHEN P.
    R.J. Reynolds Tobacco Company, Winston-Salem, NC, U.S.A.
    R.J. Reynolds conducted a multicenter clinical trial to compare smoking cessation rates with Camel SNUS, with and without smokeless tobacco health-related background information, and a nicotine lozenge. Cessation was evaluated using Fisher’s exact...
  3. TSRC, Tob. Sci. Res. Conf., 2014, 68, abstr. 07

    Retrospective analysis of data from cigarette smoke mouth level exposure (MLE) studies

    BOWMAN S.A.; CARAWAU J.; CHEN P.; NELSON P.R.
    R.J. Reynolds Tobacco Company, Winston-Salem, North Carolina, USA
    Over the past eight years, R.J. Reynolds Tobacco Company conducted a series of cigarette smoke mouth-level exposure (MLE) studies. In those studies, used cigarette filters were analyzed to determine per cigarette and daily MLE to “tar” and nicotine....
  4. TSRC, Tob. Sci. Res. Conf., 2014, 68, abstr. 33

    Assessment of exposure biomarkers in U.S. consumers of snus, moist snuff, cigarettes, and dual use

    CARAWAY J.W.; JONES B.A.; CHEN P.; BORGERDING M.F.
    R.J. Reynolds Tobacco Company, Winston-Salem, North Carolina, USA
    Biomarkers of exposure (BoE) to constituents in tobacco products and tobacco smoke were assessed in adult, U.S. tobacco consumers who participated in a multi-center, cross-sectional study. A total of 320 subjects (267 males/53 females) were enrolled...